You are here


Board Statements

ESSCB Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras

On November 14, 2011, the ESSCB Funding Committee voted to adopt a Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras, which was developed and...

read more

ESSCB Statement on the Compensation of Oocyte Donors

June 11, 2009 -- The ESSCB adopted a resolution regarding the compensation of women donating oocytes solely for research purposes and issued a statement...

read more

ESSCB Board Comments on NIH Draft Guidelines

May 26, 2009 -- The Empire State Stem Cell Board today submitted comments to the National Institutes of Health on NIH's Draft Guidelines for Human Stem Cell Research.


read more

New Model Informed Consent Forms

ESSCB Model Informed Consent Forms On November 14, 2011, the ESSCB Funding Committee approved five model informed consent forms developed by the ESSCB Ethics Committee. The forms provide guidance...

read more

News Releases

Michel Sadelain recognized for Thalassemia work

Dr. Michel Sadelain, at Memorial Sloan-Kettering Cancer Center, was recognized for his efforts to develop a new stem cell-based therapy for β-thalassemia patients by the Sultan Bin Khalifa International Thalassemia Award.

read more

Endothelial Cells Show Tissue-Specificity

A new paper from Shahin Rafii's lab profiles endothelial cells and finds they have tissue-specific characteristics.

read more

Nail Stem Cells Coordinate Nail Growth and Digit Regrowth

A new paper published in Nature from the lab of Mayumi Ito at NYU describes the role of nail stem cells in coordinating both nail growth and regrowth of digit-tips after amputation in mice.

read more

Stimulation of Endogenous Neural Progenitor Cells Slows the Progression of Huntington’s Disease

read more

Glioma Progenitor Cells Have a Unique Gene Expression Profile

New research from Steven Goldman’s lab identifies potential therapeutic targets in glioma tumor progenitor cells.

read more

NANOG Recruitment of TET Aids Reprogramming

Jianlong Wang, Ph.D., and colleagues report that NANOG aids in reprogramming to establish pluripotency by recruiting TET proteins that act to remove DNA methylation.

read more

A New Cell-Based Therapy to Treat Leukemia

Investigators at Memorial Sloan-Kettering use genetic engineering of T-cells to target cancerous B-cells in patients.

read more

A New Source of Cancer in the Ovary

Drs. Alex Nikitin and Grigori Enikolopov identify a stem cell niche in ovarian epithelium that is disposed to cancer.

read more

NYSTEM Funded Scientist Receives Audacious Idea Prize From National Eye Institute

NYSTEM funded scientist and clinician, Dr. Jeffrey Stern, receives Audacious Idea prize from the NEI to repair retina by activating resident stem cells.

read more

Novel Scientific Technique to Help Prevent Inherited Mitochondrial Diseases

Dieter Egli, PhD, of the New York Stem Cell Foundation (NYSCF) and Mark Sauer, MD, at the Columbia University Medical Center developed a novel technique to prevent the transmission of defective mitochondria in humans.

read more